TAK Short Interest
Takeda Pharmaceutical Company Limited
1W: +1.1%
1M: +9.2%
3M: +14.3%
YTD: +29.9%
1Y: +44.8%
3Y: +51.9%
5Y: +70.8%
$20.27
-0.16 (-0.78%)
Weekly Expected Move ±3.0%
$19
$20
$20
$21
$21
Credit Risk of going bust: lower than 78% of companies Debt: 32.7% of company value Bonds: $208.5M held by 194 funds, 85 bp over Treasuries → details ▾
If the stock fell to about $0.49 (down 98%), Takeda Pharmaceutical Company Limited would be worth roughly what it owes.
Total debt $31.29B against a stock market value of $64.51B.
Distance to default 9.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $17.29B (short-term plus half of long-term), stock volatility 21.6%; Altman Z'' 1.53. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Total debt $31.29B against a stock market value of $64.51B.
Distance to default 9.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $17.29B (short-term plus half of long-term), stock volatility 21.6%; Altman Z'' 1.53. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Short Volume Summary
2026-10-2636.0%
Short Ratio
of total volume
36.4%
20-Day Avg
33.4%
50-Day Avg
▼ Falling
5-Day Trend
0.5M
Short Volume
1.3M
Total Volume
Daily Short Volume Ratio
Short Volume vs Total Volume
Exchange Breakdown
2026-10-26| Exchange | Short Volume | Total Volume | Short % |
|---|---|---|---|
| NASDAQ | 435,933 | 1,092,107 | 39.9% |
| NYSE | 30,802 | 198,130 | 15.5% |
| BATS | 1,591 | 11,157 | 14.3% |